Your browser doesn't support javascript.
loading
Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.
Natalucci, Giancarlo; Latal, Bea; Koller, Brigitte; Rüegger, Christoph; Sick, Beate; Held, Leonhard; Fauchère, Jean-Claude.
Afiliação
  • Natalucci G; Department of Neonatology, University Hospital Zurich, Zurich, Switzerland.
  • Latal B; Child Development Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Koller B; Department of Neonatology, University Hospital Zurich, Zurich, Switzerland.
  • Rüegger C; Department of Neonatology, University Hospital Zurich, Zurich, Switzerland.
  • Sick B; Epidemiology, Biostatistics, and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.
  • Held L; Epidemiology, Biostatistics, and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.
  • Fauchère JC; Department of Neonatology, University Hospital Zurich, Zurich, Switzerland.
JAMA ; 324(22): 2324-2327, 2020 12 08.
Article em En | MEDLINE | ID: mdl-33289818
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recém-Nascido Prematuro / Eritropoetina / Fármacos Neuroprotetores / Transtornos do Neurodesenvolvimento Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Child, preschool / Humans / Newborn Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recém-Nascido Prematuro / Eritropoetina / Fármacos Neuroprotetores / Transtornos do Neurodesenvolvimento Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Child, preschool / Humans / Newborn Idioma: En Ano de publicação: 2020 Tipo de documento: Article